⚠
✓
Benitec Biopharma
Benitec Biopharma
Sector: Healthcare
Description
The Sydney-based Benitec Biopharma (ASX: BLT), established in 1995, is a clinical-stage biotechnology company which develops novel genetic medicines in laboratories in Hayward, California (USA), with collaborators and licensees around the world. It has a patent over DNA-directed RNA interference or ddRNAi platform, which combines RNA interference, or RNAi, and gene therapy to develop medicines that assist in silencing of disease-causing genes following a single administration for a sustained period of time.Peers
ANP
Antisense Therapeutics Ltd.
PTX
Prescient Therapeutics Limited
CYP
Cynata Therapeutics Limited
NOX
Noxopharm Limited
MRNA
Moderna Inc
CHM
Chimeric Therapeutics Limited
NVAX
Novavax Inc
BPH
BPH Energy Limited
PFE
Pfizer Inc
NYR
Nyrada Inc.
SKN
Skin Elements Ltd
IMU
Imugene Limited
Related Articles
Loading...